The multiple indicator dilution (MID) technique is often used for
investigation of the kinetic behavior of substrates and metabolites in
eliminating organs. The present study was a systematic comparison of
the utility of the Goresky model (GM) (a structural model) and the
mixed-boundary dispersion model (DM) (a stochastic model) in the
interpretation of influx, efflux, and removal (sequestration) coefficients, with data generated from rat liver-perfusion/MID studies.
Although the GM and the DM are equivalent in their descriptions of
membrane transport, they differ in their classifications of the
dispersion of blood-borne elements. For the DM, the dispersion is an
inverse Gaussian distribution of vascular transit times; for the GM, it
is accounted for by the dispersion observed among noneliminated
reference indicators (e.g. labeled red blood cells, albumin, sucrose, and H2O) or the derived
reference. In this study, previously published rat liver-perfusion/MID
data obtained for the glutathione conjugate of bromosulfophthalein and
hippuric acid, compounds that exhibit saturable carrier-mediated
transport, with the GM were reanalyzed with the two-compartment DM.
When the fitted values for volume and transfer coefficients were
compared, good correlation was found between the fitted vascular volume for the DM and the vascular volume for the reference indicator for the
GM. The influx coefficients were generally similar between the models,
but improved correspondence was observed when the DM was modified to
include the large-vessel transit time. In contrast, the efflux and
sequestration coefficients obtained for the DM did not correspond well
to those from the GM. The disagreement was due, in part, to differences
in the interpretation of the late-in-time component of the reference
transit time distribution curve, which was not described well by the
DM. Consequently, the residence time distribution and the relative
dispersion were underestimated by the DM.
 |
Introduction |
There has been major progress
made in the past three decades in the field of modeling of the liver
for the processing of drugs and metabolites. All of the models feature
the physiological determinants of clearance, i.e. organ
blood flow, vascular and tissue binding, membrane permeability, and
enzymatic activity (Vmax) and affinity (KM) of intracellular enzyme systems
and/or excretory apparati for the removal of substrates. Several useful
mathematical models that inter-relate the deterministic variables have
been developed to describe temporal events and, in particular,
steady-state events, wherein drug and metabolite binding to liver
tissue is completed and does not contribute to drug loss. Accordingly,
the liver has been viewed as a well-mixed compartment ("well-mixed"
model) (Rowland et al., 1973
; Pang and Rowland, 1977
) or as
an organ receiving a series of nonsegregated parallel flows surrounded
by identical single sheets of hepatocytes of uniform enzymatic
activity ("parallel tube" model) (Winkler et al., 1973
).
These models have been construed as being too extreme and idealized;
because there is either infinite (well-stirred model) or no (parallel
tube model) mixing, they are unable to describe the asymmetrical
outflow profiles or RTDs1
observed after bolus dosing. The inadequacy has been explained on the
basis of heterogeneities in flow (Miller et al., 1979
; Bronikowski et al., 1987
) and a high degree of geometric
branching within the liver, which provide an intermediate mixing or
dispersion. This necessitates the reselection, refinement, or
development of models that could describe the observations.
The barrier-limited, distributed, capillary transit time model of
Goresky (Goresky, 1963
; Goresky et al., 1973
) and the
adaptation (Roberts and Rowland, 1985
, 1986
) of the DM of Perl and
Chinard (1968)
with closed boundary conditions (Danckwerts, 1953
) are such model developments. These describe curve models that resemble the
outflow dilution profile observed after pulse injection, and they
recognize that the shape and magnitude of the solute outflow concentration-time curve (the dilution profile) are complex functions of the interrelationships among blood and tissue binding, blood flow,
vascular micromixing and flow heterogeneity, and cellular influx,
efflux, and sequestration (metabolism or excretion). Many established
principles have evolved through modeling of outflow data from
experiments that encompass bolus injection of a dose containing a
mixture of multiple noneliminated indicators and labeled tracer
substrate; in these instances, differentiation among the injected
species is enabled by the use of differential labeling and analyses
(multichannel
and
spectrometry). The kinetics of the diffusible
tracer reflect those under steady-state conditions for the bulk
compound, as mandated in tracer methodology. This MID technique, which
was first introduced to assess the behavior of noneliminated reference
substances for the understanding of liver physiology (Goresky, 1963
),
has become a useful experimental tool to provide mechanistic insight
into the processes of transport and irreversible loss of the
tracer-labeled substrate, especially in single-pass, rat
liver-perfusion experiments, wherein the recirculation of solutes,
which presents an added complication in vivo, is avoided (Wolkoff et al., 1979
; Schwab et al., 1990
; Geng
et al., 1995
).
The GM and the mathematical formulations have a long history, first
being used for descriptions of the handling of endogenous compounds by
dog liver in vivo (Goresky et al., 1973
) and then being extended to analyses of xenobiotics (Schwab et al.,
1990
; Geng et al., 1995
) and metabolic processing (Pang
et al., 1994
) in perfused rat liver. The approach involves
the construction of a vascular reference curve based on an initial
consideration of the binding and distribution properties of the
diffusible solute in the vasculature and then appraisal of the outflow
curve for the labeled tracer with respect to this reference (Schwab
et al., 1990
). In the past decade, the DM has been
reintroduced and modified to describe substrate processing within the
liver (Yano et al., 1989
, 1990
, 1991
; Evans et
al., 1991
, 1993
; Díaz-García et al., 1992
; Hussein et al., 1994
; Chou et al., 1993
,
1995
; Yasui et al., 1995a
; Ohata et al., 1996
;
Nishimura et al., 1996
; Ueda et al., 1997
). The
model has been extended to the two-compartment DM, with recognition
that the sinusoidal membrane of the liver is a transport barrier to
solutes, producing compartmentalization of the vascular and cellular
compartments.
Close examination of the GM and the DM reveals both similarities and
differences; the models share common mathematical descriptions of
cellular events such as transmembrane transfer, cellular drug metabolism, and biliary excretion (fig.
1), as first noted by Rowlett and Harris
(1976)
. These models typically characterize cellular events by the use
of influx (k12), efflux
(k21), and sequestration
(ke) coefficients (see definitions in
table 1). However, the GM and the DM
differ in their descriptions of the shapes of the transit time
distributions of their respective vascular reference curves.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic representation of solute handling
at the level of a single sinusoid.
The solute enters the liver with flow Q and is processed
in a distributed-in-space fashion. At each point, drug in plasma
(concentration, CP) exchanges with that in tissue
(Ct). Sinusoidal membrane transfer coefficients are denoted
by k12 and k21, the
influx and efflux coefficients, respectively, whereas the cellular
sequestration coefficient is represented by
ke (see table 1 for definitions).
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 1
Interrelationships between influx, efflux, and sequestration
coefficients for the DM and the GM and their physical equivalents
|
|
Because of the pervasive use of both models in the interpretation of
MID data to provide mechanistic insight into hepatic drug processing,
there is the need to fully understand the consistency of both models
with the data. The intent of this report was, therefore, to compare the
ramifications of the GM and the DM to gain a better understanding of
the two methods and their implications for hepatic drug processing.
From a practical standpoint, it is apparent that the GM is
experimentally and computationally more demanding than the DM because
of the requirement for noneliminated reference indicators. We therefore
became interested in assessing the similarities and differences in the
analysis of dilution data by the DM compared with the GM because the
solutions are more readily available, with inclusion of fewer or no
reference indicators. Data that had been processed by the GM with
deconvolution of the sham experiments (dilution experiments without
liver) were reexamined with the DM, to allow for comparison of the two
models. We compared the fitted values of the common parameters (volumes
and transfer coefficients) used by the GM and the DM to describe the
hepatic disposition of two compounds that are bound only to albumin and
that exhibited saturable sinusoidal (carrier-mediated) transport. These
compounds were BSPGSH (Geng et al., 1995
) and HA, the
glycine conjugate of benzoate (Yoshimura et al., 1998
).
 |
Theoretical Considerations |
The GM.
For the GM, a set of noneliminated reference indicators ordinarily
accompanies the tracer-labeled substrate for injection into the liver.
The noneliminated reference indicators include 51Cr-labeled RBCs (the vascular reference, which
is distributed only in the sinusoids),
125I-labeled albumin and
14C- or 3H-labeled sucrose
(which occupy the sinusoidal plasma and the interstitial or Disse
space), and D2O [a kinetic equivalent of water
(Pang et al., 1991
) that is distributed throughout the
vascular, interstitial, and accessible cellular water spaces of the
organ]. The outflow concentrations are normalized to the injected dose (fractional recovery per milliliter), with observations of the progressive dispersion of labeled RBCs, albumin, sucrose, and then
water, based on their increasing spaces of distribution. Another
well-known property of the model is the ability of the dilution curves
for the diffusible noneliminated reference indicator to be superimposed
on the labeled RBC curve, after appropriate correction of the time and
the concentration for the difference in distribution volumes (Goresky,
1963
). The procedure revealed the existence of a transit time delay
(t0), occurring in the nondispersing region
or the large vessels, after correction for the transit times of the
input and output catheters. The transit time profiles for albumin,
sucrose, and water are superimposed on the RBC curve using the
following relationship (Yoshimura et al., 1998
),
|
(1)
|
where h(t) is the transfer function that
describes the RTD of the reference indicator after deconvolution of the
distortion caused by the inflow and outflow catheters and the injection
device. The superposition procedure, when carried out by a fitting
procedure, provides the optimized fitted values of
t0 and
, a value denoting the space
ratios [stationary to moving spaces, i.e. Disse
space/sinusoidal plasma for albumin and sucrose and (cellular water + Disse space)/(sinusoidal plasma water + RBC water) for
D2O; see table 1 for definition].
The basic premise of the GM for the study of propagation of tracers is
the use of vascular indicators for development of an appropriate
vascular reference curve. By definition, the appropriate reference
curve is the hypothetical outflow profile for a given solute that would
result if the solute were neither taken up nor eliminated by the cells.
Depending on the experimentally determined distribution of the solute
between RBCs and plasma and on plasma protein binding, the reference
curve is constructed from the combined behaviors of the labeled RBC,
albumin, and sucrose curves, to illustrate the vascular distribution of
the labeled tracer. For example, a tracer substrate that is neither
distributed into RBCs nor bound to plasma albumin is expected to behave
identically to the observed sucrose curve, in terms of the shape and
the estimated vascular distribution volume. In contrast, for a drug
that is very highly bound to plasma protein and is not distributed into RBCs, the vascular distribution of the reference compound is similar to
that for labeled albumin. By extension, a drug that is rapidly and
reversibly bound to albumin but is not bound to RBCs would have a
vascular reference curve that defines a distribution space intermediate
between those for sucrose and albumin. In such a situation, the
reference requires the construction of the following relationship (Geng
et al., 1995
),
|
(2)
|
where
ref is the apparent distribution
space (interstitial/vascular space) ratio for the tracer and
fu is the unbound plasma fraction, which
is defined by conventional methods such as equilibrium dialysis or
ultrafiltration. Another relationship is also used when the reference
is described in relation to sucrose, which is used for fitting,
|
(3)
|
where
rel is the factor that describes
the appropriate interstitial space reference for the drug. The apparent
volume for the reference curve (Vref) is
thus described with respect to that for sucrose, as
|
(4)
|
where the total volume for sucrose,
VSuc, can be obtained by moment analysis of
the sucrose curve (catheter-corrected mean transit of sucrose × plasma flow rate).
For barrier-limited tracers, the theoretical reference transfer
function may then be appropriately related to that for sucrose in
describing the extracellular behavior of the labeled tracer. The organ
transport function for diffusible labeled tracer can be calculated with
the following equation (Yoshimura et al., 1998
),
|
(5)
|
where
is the ratio of the cellular water space
(Vcell) to the sinusoidal plasma space
(Vp) and
' is
/(1 +
ref), with parameters describing the rate
coefficients for influx
(fuk1
'), efflux
(k'
1), and sequestration
(k'seq) (see definitions in
table 1). The fitting procedure furnishes estimates of
rel and the rate coefficients. These, in turn,
provide the influx and efflux rate constants
(k1 and k
1,
respectively), as defined by Goresky and co-workers (Goresky et
al., 1973
; Geng et al., 1995
; Yoshimura et
al., 1998
), and the permeability surface area products for influx
and efflux across the hepatocyte membrane (table 1). The first term of
eq. 5 represents the throughput component or material that propagates
through the system, i.e. the portion of the tracer that
passes through the liver without entering parenchymal cells; this
throughput component is obtained from eq. 5 by setting
k'
1 to 0. The second term
represents material that enters the liver cell and later returns to the
vascular compartment, or the returning component; this is given by the difference between the total outflow profile and the throughput component.
The DM.
The DM conceptualizes that the blood flowing through a labyrinth of
ramified interconnecting sinusoids is nonideal and causes a dispersion
of noneliminated and eliminated substances (Roberts and Rowland, 1985
,
1986
). There are two parameters that characterize the model,
i.e. DN, or the inverse of the
Peclet number, which describes the degree of mixing or dispersion
resulting from heterogeneous blood flow through the microvasculature,
and the efficiency number, RN, or the term
for removal
|
(6)
|
where fu is the unbound fraction,
CLint is the intrinsic clearance or the
inherent ability for removal of the unbound substrate, and
,
as defined in earlier publications (Roberts and Rowland, 1985
,
1986
), is given by P/(P + CLint), where P is the
permeability. The use of
= 1 is justified when permeabilities far
exceed the intrinsic clearance.
The dispersion observed in the outflow dilution profile for a given
solute is modeled with a second-order partial differential equation
that can be described in Laplace transformations after delineation of
the boundary conditions. In general, the mixed-boundary DM (Roberts
et al., 1988
) is preferred over the closed-boundary DM of
Perl and Chinard (1968)
(Danckwerts, 1953
; Roberts et al., 1988
) because of the ease of calculation in the former. The frequency output of a solute can be presented in the Laplace domain (Evans et al., 1991
),
|
(7)
|
where s is the Laplace operator and
w(s)H and
w(s)NH are the transfer
functions that describe the spread of solute by passage through the
hepatic and nonhepatic (inflow and outflow catheters, tubing, and
devices) regions, respectively. The transfer function of the frequency
output, f(t) or QC(t)/dose,
in the absence of the liver can be described by (Evans et
al., 1991
)
|
(8)
|
where DN,NH is the nonhepatic
DN and MTTNH is the
MTT of the reference in the sham experiment (volume of nonhepatic
portion/flow or VNH/Q).
The w(s)H value, or hepatic
transport function of the solute, may be calculated for the one- or
two-compartment DMs. The one-compartment DM is used to describe the
processing of solutes that establish rapid equilibration between the
vasculature and the cells. For the noneliminated reference, which is
not removed, the weighting function is
|
(9)
|
where VB is commonly considered as the
volume of the distribution for the noneliminated reference compound in
the central compartment and is the sum of the vascular volume and the
Disse space for albumin or sucrose and Q is the perfusate
flow rate (Evans et al., 1991
). For a solute that is removed
in the one-compartment model (Roberts and Rowland, 1986
), the following
weighting function applies,
|
(10)
|
where VB is the extracellular volume
(combined sinusoidal and Disse spaces) and
CLint is the intrinsic clearance for
removal of unbound substrate.
However, with recognition that the hepatocyte membrane is a barrier
that facilitates or retards the entry of solutes, producing different
concentrations in the vasculature and cells, the two-compartment model
has been developed for the description (Yano et al., 1989
). Elimination from the vascular (Yano et al., 1990
, 1991
)
and/or peripheral (Yano et al., 1989
; Evans et
al., 1991
, 1993
) compartments has been considered. With the
assumption that the vascular and cellular compartments are
physiological spaces that are equivalent to the central and peripheral
compartments, respectively, which are separated by the hepatocyte
membrane, cellular removal likely occurs in the peripheral compartment.
Under these circumstances, the weighting function for a solute that is
distributed between the extracellular and cellular regions in liver is
described as follows (Evans et al., 1991
),
|
(11)
|
where VB is commonly considered the
extracellular volume (combined vascular and Disse spaces) and
k12, k21, and
ke are the influx, efflux, and elimination
coefficients, respectively (fig. 1 and table 1).
For the DM, the curve form of the vascular reference is a modified
inverse Gaussian distribution, and the same function identifies the
curve profile for the vascular reference. The curve form differs from
that for the GM, which is constructed from the noneliminated references. For the DM, the VB, the
combined volume of the extracellular spaces (vascular volume + Disse
space), is equivalent to the vascular volume of distribution for the
reference in the GM. For the DM, the rate coefficients have been
defined with respect to the compartment wherein the flux originates and
have not been corrected for binding; for the GM, all of the rate
constants are defined with respect to the accessible cellular water
space (Vcell), and the permeability surface
area products have been corrected for protein binding (table 1). As in
the GM, the throughput component for the DM can be obtained by setting
k21 to 0, and the corresponding
hypothetical reference curve can be determined by setting the influx
parameter, k12, to 0 (Evans et
al., 1993
). Again, the difference between the total outflow
profile and the throughput component yields the returning component.
For the DM, the transit time of the noncapillary vessels
(t0) has not been previously considered.
The absence of this delay factor in the DM might simply have been an
oversight, or the factor might have been viewed as being unimportant in
the distortion of the impulse. In contrast, the GM describes the large vessels as a nonexchanging and nondispersing region characterized by
its transit time, t0.
 |
Materials and Methods |
Data Set.
Data from single-pass, rat liver-perfusion/MID experiments were used in
the present analysis. The data had been previously analyzed using the
GM. In the first set of studies (N = 12), a bolus
injection of [3H]BSPGSH was introduced
simultaneously with the reference indicators (51Cr-labeled RBCs,
125I-albumin,
[14C]sucrose, and D2O)
(Geng et al., 1995
), under steady-state conditions, with
various concentrations of BSPGSH (20-214 µM). Similarly, in another
set of studies (N = 19), [3H]HA
was injected, together with the set of noneliminated reference indicators, with a background concentration of HA (1-930 µM), under
steady-state conditions, with or without the presence of lactate (20 mM) or benzoate (10-873 µM), compounds that were found to inhibit HA
uptake (Yoshimura et al., 1998
). The outflow of [3H]BSPGSH or [3H]HA
was expressed as the fraction of the administered dose eluting per
second [C(t)/dose] or as the frequency output
[f(t) or
C(t)Q/dose].
Data Analysis.
The frequency output was analyzed according to the DM (Evans et
al., 1991
). Data from sham experiments, in which labeled RBCs were
injected into the inflow and outflow catheters, were used to evaluate
w(s)NH (eq. 8). Preliminary
fits indicated that eq. 8 was unable to describe the observed
exponentially multiphasic decline in the sham experiments. Therefore,
w(s)NH was empirically fitted to the two-compartment DM for noneliminated references where
there is no elimination
|
(12)
|
where DN,NH is the nonhepatic
DN, VNH is the
volume of the nonhepatic experimental system, Q is the
perfusate flow rate, and k56 and
k65 are the parameters accounting for the
biphasic decline. Least-squares fitting of the sham experiment data to eq. 12 yielded estimates of 0.0163, 1.04 ml, 0.105 sec
1, and 0.388 sec
1
for DN,NH, VNH,
k56, and k65,
respectively.
Because we had previously demonstrated that both BSPGSH and HA exhibit
barrier limitation (carrier-mediated saturable uptake processes), the
hepatic transfer function,
w(s)H, for the
two-compartment DM (eq. 11) was used. Since only hepatic uptake and
efflux occur for HA, the hepatic transport function in eq. 11 was
modified by setting ke = 0.
Further analysis of the outflow data was performed, in which the DM
included a lag time, t0, that characterizes
the hepatic large-vessel transit time of the GM. The
t0 was obtained either from the GM or from
the fitting procedure. In these analyses, the frequency output was
described by the following equation in the Laplace domain,
|
(13)
|
The MTT and the CV2 of the diffusible
tracers were estimated for the DM according to the equations provided
by Yano et al. (1989)
. The MTTs and variances from the GM
were obtained by integration of the model functions with 1000 points
using the trapezoid rule, with or without monoexponential
extrapolation. The number of points was large enough that there should
be no problem with accuracy. From these, correction of the MTTs and
CV2 for the catheter was made.
Fitting.
The frequency outputs were fitted to eq. 7 or 13 with the use of a
weighted least-squares minimization procedure, using a Levenberg-Marquardt algorithm, found in the program SCIENTIST (Micromath Scientific Software, Salt Lake City, UT). Numerical inversion of the Laplace transforms was accomplished using the Piessens-Huysmans algorithm used by the program. All parameters (DN, VB, the
transfer coefficients, and, where appropriate,
t0) were estimated during the fitting
procedure with the weighting chosen at 1/observed value. For each
experiment, the frequency output data were modeled with the
two-compartment DM without inclusion of t0
(set A), with t0 obtained from GM (set B),
and with fitted t0 (set C).
Statistical Analysis.
All data are presented as mean ± SD. The paired t
statistic was used for the comparison of paired data of sets A or C of
the DM with those of the GM. Data of set A were compared with those of
set C, because these are data fits of the DM with and without t0, respectively. The MSC (SCIENTIST for
Windows manual; Micromath Scientific Software), a modified Akaike
information criterion, was used to compare the goodness of fit to the
model; a larger value for MSC suggests a superior model.
 |
Results |
BSPGSH Data.
Good correlation was obtained between the estimated apparent
VB from sets A, B, and C in the DM and the
vascular volume for the reference in the GM (R > 0.90)
(fig. 2 and table
2). However, these values (approximately
3-3.4 ml) were significantly greater than the volume for the vascular
reference according to the GM (2.7-3 ml). Similarly, an excellent
correlation (R > 0.91) was found between the influx
coefficients determined by the DM (k12) and
those determined by the GM
(fuk1
') (fig.
3). Paired analysis of the
k12 values estimated in sets A, B, and C
failed to show differences between the DM and the GM
(p > 0.05) (table 2), although clearly the
correlation improved with inclusion of t0
(fig. 3). In contrast, values for k21 and
ke obtained for the DM did not correspond
well to the respective efflux and sequestration coefficients obtained
from the GM (figs. 4 and
5 and table 2). The DM values for
k21 and ke
were higher than those from the GM (set C compared with set A,
p < 0.01) (table 2). The addition of
t0 to the DM improved the correlation
between the respective parameters k21 and
ke (compare fig. 4A with fig.
4, B and C, and compare fig. 5A with
fig. 5, B and C) and increased
DN significantly (almost 3-fold) (table 2).
View this table:
[in this window]
[in a new window]
|
TABLE 2
Summary of fitted parameters from the DM (set A, DM without t0;
set B, DM with GM t0; set C, DM with fitted t0) and the
GM
|
|

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 3.
Relationship between influx coefficients
(k12) determined by the DM and the GM for
BSPGSH (data from Geng et al., 1995 ).
The dashed lines were established by linear regression
(equations shown, with correlation coefficients, R), whereas the
solid lines are the lines of identity.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
Relationship between efflux coefficients
(k21) determined by the DM and the GM for
BSPGSH (data from Geng et al., 1995 ).
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 5.
Relationship between sequestration
coefficients (ke) determined by the DM and the GM for
BSPGSH (data from Geng et al., 1995 ).
|
|
The fit of the BSPGSH outflow curve according to the DM was further
explored by simulation of the reference curves (fig.
6A) with the fitted parameters
for DN and VB
for set C (see example, at a BSPGSH concentration of 214 µM) and was
compared with that of the GM. For the GM, the reference curve fell
between that of labeled sucrose and labeled albumin, because there is
substantial binding of BSPGSH to albumin (unbound fraction = 0.1);
the reference curve decayed slightly faster than the sucrose curve.
However, for the DM, the downslope of the reference curve decayed much more rapidly. The predicted throughput component for the DM was much
smaller than that for the GM; consequently, the returning component was
greater (fig. 6B). All of these discrepancies existed even
though the fit of the data to the GM was only marginally better than
that for the DM.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 6.
Model fit to a representative MID experiment
conducted with [3H]BSPGSH (214 µM).
A, reference curves for the DM (set C) and the GM;
B, the fitted line and throughput and returning
components for the DM (set C) and the GM.
|
|
HA Data.
Fitting was successful for all experimental data in sets A and C. However, convergence was obtained for only 14 of the 19 experiments in
set B, because of the unexpectedly large t0
obtained with the GM. Hence, data from only the 14 experiments were
reported among all data sets. The estimates of
VB for sets A, B, and C correlated well
with the volume for the reference determined by the GM (3.0 ± 0.5 ml) (fig. 7 and table 2). The
k12 of the DM was moderately correlated
with the influx coefficient of the GM in sets A and C (fig.
8). Inclusion of
t0 in the DM did not improve the
correspondence for k12 between the DM and
GM estimates (compare fig. 8A with fig. 8, B and
C). However, improved correspondence in the efflux parameter
(k21) was observed for sets B and C with GM
values when t0 was included in the DM
(compare fig. 9A with fig. 9,
B and C). Again, a significant increase of the
DN value was observed with the inclusion of
t0 (table 2).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 8.
Relationship between influx coefficients
(k12) determined by the DM and the GM for HA (data
from Yoshimura et al., 1998 ).
The dashed lines were established by linear regression
(equations shown, with correlation coefficients, R), whereas the
solid lines are the lines of identity.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 9.
Relationship between efflux coefficients
(k21) determined by the DM and the GM for HA (data from
Yoshimura et al., 1998 ).
The dashed lines were established by linear regression
(equations shown, with correlation coefficients, R), whereas the
solid lines are the lines of identity.
|
|
A representative fit of the indicator dilution profile for
[3H]HA (930 µM) is shown in fig.
10. For the GM, the reference curve closely followed that for sucrose (fig. 10A), owing to the
modest unbound fraction of HA in plasma (unbound fraction = 0.54).
The reference curve for the DM lay close to the sucrose curve at early time points and then decayed in a monoexponential fashion. The model
fit to the [3H]HA data was similar for the GM
and the DM, although the GM tended to describe the late-in-time data
better (fig. 10B). For [3H]HA, the
DM estimated a greater throughput and thus a smaller returning
component, compared with the GM.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 10.
Model fit to a representative MID
experiment conducted with [3H]HA (930 µM).
A, reference curves for the DM (set C) and the GM;
B, the fitted lines and throughput and returning
components for the DM (set C) and the GM.
|
|
The MTT for BSPGSH estimated with the DM was significantly smaller than
that from the GM; however, similar values were found for HA (table
3). Values for CV2
were generally lower for the DM than for the GM; however, significance was found only for HA and not BSPGSH.
 |
Discussion |
In this report, we compared the fitted values for the common
parameters that characterize the hepatic disposition of two solutes with saturable uptake (BSPGSH and HA) in the GM and the DM. From the
various parameter estimates of the two models, several conclusions can
be drawn. The first regards the similarities between the volume for the
appropriate reference in the GM and the apparent volume of distribution
in the DM and among the influx constants; the second, the greater than
predicted dispersion of the vascular reference curves; and the third,
the influence of the large-vessel transit time delay on
DN and the rate coefficients.
Results on the fitted volumes of the vasculature
(VB) for the basic DM (set A, without
t0) were similar to those for the reference from the GM [VSuc(1 +
rel)]. The closeness of the estimates
suggests that the fitted value derived from the DM provides a sound
estimate of the apparent volume of distribution for the solute in the
vasculature (defined as "the reference" in the GM). This volume is
not the combined volumes of the sinusoidal blood and the Disse space, as originally conceived. However, the difference is expected to be
small, because the apparent volume of distribution for the solute
approximates the total albumin space or the total sucrose space for
drugs that are totally bound or unbound to albumin, respectively.
Moreover, the a priori assignment of
VB as 15% of the wet liver mass, as
adopted in many reports (Evans et al., 1991
, 1993
),
underestimates the volume for the reference in the DM and leads to poor
fits (data not shown).
The influx coefficient (k12) of the DM was
found to be highly correlated with that
(fuk1
') of the
GM (figs. 3 and 8). The observation was the result of the similarities
of the respective reference curves at the early times (upswing portions
of figs. 6 and 10), such that the predictions of the two models
coalesced, as noted by Rowlett and Harris (1976)
. However, the
respective reference curves eventually deviated, mostly for the
later-in-time segments or the "tails" of the dilution profiles,
such that the efflux and sequestration coefficients that characterize
the returning component for the labeled tracer were also dissimilar.
For this reason, the fit to the GM is superior (compare CD values in
table 2) to that to the DM, although the fit to the DM is generally quite good, especially for the early data.
To investigate whether the large-vessel transit time could account for
these differences, we included the lag time parameter t0 in the DM, either as an assigned
parameter (value of t0 from the GM, set B)
or as a fitted parameter (set C). Inclusion of t0 in the DM (sets B and C) slightly
improved the correspondence of influx, efflux, and sequestration
coefficients between the DM and the GM. The most significant change
occurred with DN, which increased
approximately 2-3-fold as a direct result of the incorporation of
t0 (table 2). This was also found in an
analysis of the DM with closed- or mixed-boundary conditions, with or
without t0 as a fitted parameter, in rat
liver-perfusion/MID studies conducted with catheters of varying
lengths, in which different DN estimates were observed for the noneliminated reference indicators in the absence
of t0 (Schwab et al., 1998
). The
inclusion of t0 in the DM provided a common
DN (~0.22) for the noneliminated
indicators (labeled RBCs, albumin, sucrose, and water), as expected
with the dispersive capability of the liver. The universality of this value provides full justification for including the time delay. The
finding suggests that, after the initial delay, the same extent of
dispersion exists for the noneliminated references, with a common
DN (varying from 0.16 to 0.31 among
preparations), regardless of the distribution volumes or catheter sizes
(Schwab et al., 1998
). Interestingly, the goodness of fit
was also improved when t0 was considered in
the DM in the present analysis (higher values for the CD and MSC)
(table 2). The hypothesis that the large nonexchanging vessels would
not add to the dispersion of solutes in the liver thus appears valid.
Further support for the use of t0 is
provided by the excellent superposition of the curves for the
diffusible noneliminated indicators onto the labeled RBC curve (scaling
the time and concentration terms by the ratio of the distribution
volumes) when the elapsed time is corrected for
t0 (Goresky, 1963
). Audi et al.
(1994
, 1995
) have demonstrated that, in the lung, virtually all of the
dispersion occurs in the capillary beds and only an undetectable amount
of dispersion exists in the arterial and venous trees. Taking these
findings together, we conclude that the addition of
t0 for fitting is an appropriate refinement
of the DM for hepatic modeling. However, there appears to be no
consistent relationship for the t0 values
between the DM and the GM (fig. 11);
the t0 values for BSPGSH were quite similar for the DM and the GM, but the fitted t0
values for the DM were consistently lower than those obtained by the
superposition procedure of Goresky.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 11.
Plots of the fitted
t0 for the DM vs. the
t0 for the GM, obtained with the
superposition procedure, for BSPGSH (A) and HA
(B).
|
|
Because the large-vessel transit time could not explain the major
differences in the estimates for the transfer coefficients obtained
with the GM and the DM, differences in the vascular reference curves
for BSPGSH or HA might be the reason for the disparities. For the DM,
the reference curve is an inverse Gaussian distribution of transit
times and is described by a rapid upslope followed by a monoexponential
decay; for the GM, the reference curve is molded by the shapes of
curves for the appropriate reference indicators, i.e.
albumin and sucrose and their dispersions within the liver, because of
the partial binding of the solute to albumin (figs. 6 and 10). It was
readily apparent that the reference curves for the DM and the GM were
similar at early time points but diverged after 2 or 3 MTTs. The small
difference in the early reference curves reflected the similarities in
estimates for k12 determined by the two
models. Whereas the reference curve for the DM declined monoexponentially, the corresponding profile for the GM decayed in a
fashion that closely resembled that of sucrose, with a slightly protracted tail. This difference in the downslopes of the reference curves brought about uncertainties in the throughput and returning components. There was lack of a definitive pattern observed for BSPGSH
and HA with regard to the throughput and returning components (figs. 6
and 10). The throughput component is highly correlated with the
magnitude of k12 and the shape and
downslope of the reference curve. When the estimated
k12 for the DM is greater than that for GM,
the throughput component for the DM is greater than that for the GM
and, conversely, the returning component is lower. A greater disparity
exists for the returning component, which is obtained as a difference
curve, especially when it is small. This is manifested as highly
variable estimates for k21 and
ke with the DM and the GM.
It must be reemphasized that, for the GM, the reference curve is
constructed from the full complement of noneliminated reference indicators, and its basis should be firmly established. Comparison of
the outflow profile for the diffusible labeled tracer with that for the
reference would, in essence, correct for the heterogeneities in
capillary transit time and account for micromixing or geometric tortuosity, as claimed by some investigators of liver physiology (King
et al., 1996
; Weiss, 1997
). The suitability of the model is
apparent when the late-in-time data are well fitted and displayed in
semilogarithmic plots (high CD values) (table 2). This was seldom
performed with the DM for noneliminated reference indicators and the
eliminated tracer solute. The late-in-time observations that highlight
the dispersion within the system showed a systematic deviation from the
fitted curve for the DM. For this reason, the MTT and
CV2 for the DM are underestimates (table 3).
However, in some instances, the tailing profile for tracers such as
enalaprilat (Schwab et al., 1990
) and BSPGSH (in Eisai hyperbilirubinemic mutant rats) (Geng et al., 1998
) could
not be explained by the present DM and GM but could be modeled by the
presence of a deep intracellular pool (equivalent to three-compartment DM fitting; fits not shown). In other instances, the influence of tight
intracellular binding or slow diffusion (Luxon and Weisiger, 1993
;
Yasui et al., 1995b
) could explain the unexpected RTDs of these solutes. For the DM, it should also be recognized that parameter identification was poor for efflux and removal, especially when the
presence of a deep intracellular pool was evoked (fits not shown).
Moreover, one must recognize the strong interrelationships between
VB and k12, in
addition to VB and
DN, with the fitting procedure.
The comparison, however, reveals the utility of the DM. To reiterate a
few points, DM is simpler with respect to computation and experimental
strategy than the GM. The volume for the reference and the influx
coefficient (and therefore uptake clearance) are well estimated, and
this should provide insight into the uptake mechanism for solutes.
Also, the exact amount of the dose can be verified independently using
the area of the reference curve, thus circumventing experimental errors
in its volumetric assessment. For optimization of the DM, however,
model fitting with t0 is necessary to
provide improved estimates of VB and
k12. Furthermore, proper application of
tracer methodology necessitates the use of tracers in the injection
dose under steady-state conditions for the bulk unlabeled compound. The
appropriateness of the curve function for the sham experiment (without
liver) must be demonstrated, because it is of paramount importance in
the deconvolution procedure for the tracer outflow profiles. If the
simple transfer function with monoexponential decay (eq. 8) were used
instead of the biphasic decay curve model (eq. 12) in the analysis of
the sham experiment data for the DM in the present study,
DN, VB, and
t0 would be overestimated, whereas
k12, k21, and
ke would be underestimated in the labeled tracer
data (comparison not shown). Experimentally, it is necessary that data
collection be extended beyond 3 MTTs, and it is imperative that the
radiolabels quantified are identical to the quantities of the named
drug or its metabolites. These recommendations ensure the proper use of
indicator dilution profiles in providing mechanistic insight into drug
uptake processes.
Received November 4, 1997; accepted December 23, 1997.
This work was supported by the National Institutes of Health
(Grant GM38250) and the Medical Research Council of Canada (Grants MA-9104 and MT-11228). R.G.T. was supported by Graduate Research Scholarships from Merck Frosst Canada and by the Pharmaceutical Manufacturers Association of Canada-Health Research Foundation and the
Medical Research Council of Canada. This work was presented, in part,
at the American Association of Pharmaceutical Scientists Annual Meeting
(Boston, MA) in November 1997.
Abbreviations used are:
RTD, residence time
distribution;
RBC, red blood cell;
MID, multiple indicator dilution;
GM, Goresky model;
DM, dispersion model;
BSPGSH, bromosulfophthalein
glutathione conjugate;
HA, hippuric acid;
MTT, mean transit time;
CV2, relative dispersion;
CD, coefficient of determination;
t0, large-vessel transit time;
VB, blood volume;
DN, dispersion number;
MSC, model selection
criterion..